CAMBRIDGE, Mass., Oct. 9, 2025 /PRNewswire/ — Leap Therapeutics (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it has closed its previously announced private placement led by Winklevoss Capital […]
CAMBRIDGE, Mass., Oct. 9, 2025 /PRNewswire/ — Leap Therapeutics (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it has closed its previously announced private placement led by Winklevoss Capital […]
CAMBRIDGE, Mass., Oct. 9, 2025 /PRNewswire/ — Leap Therapeutics (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it has closed its previously announced private placement led by Winklevoss Capital […]
